Kimberly-Clark Corporation (KMB) - 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Kimberly-Clark Corporation (KMB) is a global consumer goods company. A material strategic shift occurred on June 5, 2025, with the announcement of a joint venture with Suzano S.A. involving the International Family Care and Professional (IFP) segment. Consequently, the IFP Business is now reported as discontinued operations for all periods presented. Continuing operations are organized into two segments: North America (NA) and International Personal Care (IPC).
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | 2025 (YTD) | 2024 (YTD) | Change |
|---|---|---|---|
| Net Sales (Continuing) | $8,217 million | $8,557 million | -4.0% |
| Operating Profit (Continuing) | $1,223 million | $1,254 million | -2.5% |
| Net Income (Total) | $1,085 million | $1,211 million | -10.4% |
| Diluted EPS (Total) | $3.23 | $3.52 | -8.2% |
| Cash from Operations | $1,097 million | $1,459 million | -24.8% |
| Total Debt (Continuing) | $7,241 million | $7,418 million | -2.4% |
| Cash & Equivalents | $657 million | $1,163 million | -43.5% |
Note: Net Sales and Operating Profit figures above reflect continuing operations only. Discontinued operations contributed $171 million to net income for the six months ended June 30, 2025.
Material Changes vs. Prior Period
- Revenue Decline: Net sales from continuing operations decreased 4.0% year-over-year, driven by divestitures (PPE business, private label diaper exit) and unfavorable currency translation (-1.7%), partially offset by organic sales growth of 1.2%.
- Margin Pressure: Gross margin decreased 220 basis points to 36.1%. Adjusted gross margin (excluding transformation charges) decreased 120 basis points due to unfavorable pricing net of cost inflation and tariff impacts, partially offset by productivity savings.
- Transformation Costs: The "2024 Transformation Initiative" incurred $199 million in pre-tax charges for the six months ended June 30, 2025, compared to $235 million in the prior year. Cumulative charges through June 30, 2025, total $656 million.
- Cash Flow: Operating cash flow declined significantly ($362 million decrease) due to lower operating profit and unfavorable changes in working capital, including higher cash payments for the transformation initiative.
- Discontinued Operations: The IFP segment, previously part of continuing operations, is now classified as discontinued. It generated $171 million in net income for the six-month period.
Guidance, Outlook, and Risks
- IFP Transaction: Expected to close in mid-2026. KMB will retain a 49% equity interest in the joint venture, while Suzano acquires 51% for approximately $1.7 billion. Closing is subject to regulatory approvals.
- Transformation Outlook: The initiative is expected to be completed by the end of 2026, with total pre-tax costs of approximately $1.5 billion and expected gross productivity savings of $3.0 billion.
- Tariff Impact: Management estimates incremental costs from new U.S. and global tariffs to be approximately $170 million in 2025, primarily impacting the North America segment.
- Capital Spending: Full-year capital spending is anticipated to be between $1.0 billion and $1.2 billion.
- Legal & Geopolitical Risks: Ongoing DOJ investigation regarding former Avanos Medical business (qui tam matter settled for immaterial amount). Continued exposure to the war in Ukraine, with Russia operations representing 1-2% of global sales, subject to potential impairment or operational restrictions.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) enacted July 4, 2025, is expected to have favorable cash tax impacts in the near term.
Investor Verification Checklist
- IFP Transaction Closing: Verify progress on regulatory approvals and consultation requirements for the mid-2026 closing date.
- Tariff Mitigation: Assess the company's ability to pass on the estimated $170 million in tariff costs to consumers without significant volume loss.
- Transformation Savings: Monitor the realization of the projected $3.0 billion in gross productivity savings against the $1.5 billion in costs.
- Working Capital Trends: Review future quarters for stabilization of operating working capital, which was a primary driver of the cash flow decline.
- Discontinued Operations: Confirm the final accounting treatment and cash flow implications of the IFP separation costs ($33 million incurred in Q2 2025).